Adetowobola Odedina MD. MSc
About Adetowobola Odedina MD. MSc
Adetowobola Odedina is a Medical Safety Assessment Physician at Bristol Myers Squibb with expertise in clinical trial safety processes, risk management, and pharmacovigilance.
Current Position at Bristol Myers Squibb
Adetowobola Odedina currently holds the position of Medical Safety Assessment Physician at Bristol Myers Squibb in the United States. In this role, he is involved in ensuring the safety of clinical trials and pharmacovigilance processes within the company. His responsibilities likely include risk management, signal detection, and causality assessment, leveraging his expertise in these areas to maintain the integrity of clinical safety.
Professional Experience at Mallinckrodt Pharmaceuticals
From 2019 to 2022, Adetowobola Odedina worked as a Medical Safety Assessment Physician at Mallinckrodt Pharmaceuticals in New Jersey, United States. During his three-year tenure, he contributed to the company's clinical safety systems and processes. His role encompassed various aspects of clinical trial safety, including signal detection and risk management, ensuring the safety and efficacy of pharmaceutical products.
Research Experience at Queens Heart Institute
Adetowobola Odedina worked at Queens Heart Institute in New York from 2018 to 2019, focusing on research projects. This position allowed him to engage in medical research, contributing to the advancement of cardiology. His work likely involved gathering data, analyzing clinical outcomes, and supporting research initiatives at the institute.
Medical Advisor Role at Unilever
In Lagos, Nigeria, Adetowobola Odedina served as a Medical Advisor at Unilever from 2016 to 2017. In this capacity, he provided medical advice and consultancy, contributing to the development and safety assessment of Unilever's health-related products. His role would have involved collaborating with various departments to ensure that products met safety standards and regulations.
Educational Background in Clinical Trial Sciences
Adetowobola Odedina earned his Master of Science (MSc) in Clinical Trial Sciences from Rutgers School of Health Professions between 2018 and 2021. His studies focused on advanced practices in pharmacovigilance, clinical development, and trial safety processes. This education has equipped him with the skills necessary for managing and assessing the safety of clinical trials and pharmaceutical products.
Medical Training at Olabisi Onabanjo University
Adetowobola Odedina completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at Olabisi Onabanjo University. This foundational education provided him with extensive medical knowledge and training, enabling him to pursue a career in various medical and clinical safety roles.
Expertise in Clinical Trial Safety and Pharmacovigilance
Adetowobola Odedina possesses expertise in clinical trial safety processes and pharmacovigilance. He is proficient in risk management, signal detection, and causality assessment. Additionally, he is trained in current practices related to clinical development and safety assessment, making him a valuable asset in ensuring the safety of pharmaceutical products and clinical trials.